Skip to content
Screener

Veracyte VCYT PP&E (Net)

PP&E (Net) at other companies

Myriad Genetics logo
Myriad GeneticsMYGN
$111.5M-2.2%
Biodesix, Inc. logo
Biodesix, Inc.BDSX
$23.8M-8.9%
Castle Biosciences logo
Castle BiosciencesCSTL
$100.93M+82.1%
Personalis, Inc. logo
Personalis, Inc.PSNL
$48.44M+0.9%
Guardant Health logo
Guardant HealthGH
$150.04M+16.0%
Natera, Inc. logo
Natera, Inc.NTRA
$317.57M+67.8%

Other financials

Income statement

See full
Revenue$139.1M+21.5%
Gross profit$101.2M+27.2%
Operating income$22.6M+680%
Net income$28.7M+307%
EPS (diluted)$0.35+289%

Balance sheet

See full
Cash & equivalents$264.8M+41.0%
Total debt$39.3M-22.1%
Total equity$1.3B+12.5%
Total assets$1.4B+9.2%

Cash flow

See full
Operating cash flow$35.2M+557%
CapEx$3.0M+62.8%
Free cash flow$32.3M+810%

Valuation

See full
Market cap$3.8B+72.4%
Enterprise value$3.57B+75.8%
P/E43.1×-40.5×
P/S+2.4×

Profitability

See full
Gross margin70.9%+2.9pp
Operating margin14.3%+9.2pp
Net margin16.2%+9.1pp
FCF margin28.7%+11.7pp

Returns & leverage

See full
Return on equity6.9%+4.1pp
Debt / equity0.0×
Current ratio9.3×+4.2×

Where this comes from

Reported directly by Veracyte in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization.

The source filing: Veracyte’s 10-Q, filed May 6, 2026.

Filed
May 6, 2026, 8:07 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001384101-26-000031
Line itemMarch 31, 2026December 31, 2025
Supplies21,41620,546
Prepaid expenses and other current assets11,58710,281
Total current assets522,175488,376
Property, plant and equipment, net22,65222,192
Right-of-use assets, operating leases35,86536,599
Intangible assets, net85,86389,148
Goodwill767,154767,154
Restricted cash1,6571,648

Item 1. Condensed Consolidated Financial Statements (Unaudited)

FAQ

What is Veracyte's PP&E (net)?
Veracyte (VCYT) reported PP&E (net) of $22.65M in Q1 2026.
How has Veracyte's PP&E (net) changed year-over-year?
Veracyte's PP&E (net) increased by 0.5% year-over-year, from $22.53M to $22.65M.
What is the long-term trend for Veracyte's PP&E (net)?
Over 5 years (2020 to 2025), Veracyte's PP&E (net) has grown at a 19.8% compound annual growth rate (CAGR), from $8.99M to $22.19M.
What does PP&E (net) mean?
Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.

Ask your AI about Veracyte's pp&e (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude